drugset / Trial / NCT07285213
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioides difficile infection in Individuals 18 years of age and above.
Timeline
- Start
- 2025-12-10
- Primary completion
- 2027-04-20
- Completion
- 2028-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD5148 | Monoclonal antibody | — | Intramuscular |